Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral PTH Analog in Postmenopausal Osteoporosis
NCT01321723Phase 2Completed
- Sponsor
- Unigene Laboratories, Inc.
- Start
- Feb 2011
- Primary completion
- Oct 2011
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of PTH(1-31) in postmenopausal osteoporosis, sponsored by Unigene Laboratories, Inc.. Started Feb 2011; status: completed.
02
Drugs
PTH(1-31)
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT01321723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01321723.